A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

NCT05363358 · clinicaltrials.gov ↗
COMPLETED
Status
6086
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Takeda

Collaborators